Ophthalmic Complications in Patients With Inflammatory Bowel Disease During Anti-TNF Treatment

被引：0
|
作者：
Milani, Luciane [1 ]
Queiroz, Natalia [2 ]
Azevedo, Matheus [1 ]
Carlos, Alexandre [1 ]
Oba, Jane [3 ]
Rocha, Beatriz [1 ]
Barros, Luisa [1 ]
Sobrado, Carlos [4 ]
Goncalves, Aline [5 ]
Leite, Andre [1 ]
Sipahi, Aytan [1 ]
Damiao, Aderson [1 ]
机构：
[1] Univ Sao Paulo, Dept Gastroenterol & Hepatol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Dept Gastroenterol, Colorectal Surg Div, Sao Paulo, Brazil
[3] Univ Sao Paulo, Dept Pediat Gastroenterol, Sao Paulo, Brazil
[4] Hosp Clin Fac Med USO, Sao Paulo, Brazil
[5] Univ Sao Paulo, Hosp Clin, Sao Paulo, Brazil
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P074
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [31] Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Parlett, Lauren
    Lewis, James D.
    Haynes, Kevin
    Adimadhyam, Sruthi
    Hou, Laura
    Wolfe, Audrey
    Toh, Sengwee
    Burris, Jessica
    Dorand, Jennifer
    Kappelman, Michael D.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (08) : 1345 - 1352
  • [32] Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Parlett, Lauren
    Lewis, James D.
    Haynes, Kevin
    Adimadhyam, Sruthi
    Hou, Laura
    Wolfe, Audrey
    Toh, Sengwee
    Burris, Jessica
    Dorand, Jennifer
    Kappelman, Michael D.
    INFLAMMATORY BOWEL DISEASES, 2023,
  • [33] Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy
    Casanova, Maria Jose
    Chaparro, Maria
    Domenech, Eugeni
    Barreiro-de Acosta, Manuel
    Bermejo, Fernando
    Flores, Eva Iglesias
    Gomollon, Fernando
    Rodrigo, Luis
    Calvet, Xavier
    Esteve, Maria
    Garcia, Esther
    Garcia, S.
    Taxonera, Carlos
    Calvo, Marta
    Lopez, M.
    Ginard, Daniel
    Gomez, Maria
    Garrido, Elena
    Perez-Calle, Jose L.
    Beltran, Belen
    Piqueras, Marta
    Saro, Cristina
    Botella, Belen
    Duenas, Carmen
    Diaz, Angel Ponferrada
    Manosa, Miriam
    Iglesias, Marta
    Algaba, Alicia
    Garcia-Sanchez, Valle
    Mate, J.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2012, 142 (05) : S362 - S363
  • [34] Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy
    Jose Casanova, Maria
    Chaparro, Maria
    Iglesias Flores, Eva
    Rodrigo, Luis
    Domenech, Eugeni
    Calvet, Xavier
    Garcia-Planella, Esther
    Bermejo, Fernando
    Taxonera, Carlos
    Barreiro-de Acosta, Manuel
    Garcia, Acosta S.
    Ginard, Daniel
    Luis Cabriada, Jose
    Garrido, Elena
    Gomez-Garcia, Maria
    Perez-Calle, Jose L.
    Saro, Cristina
    Piqueras, Marta
    Beltran, Belen
    Esteve, Maria
    Botella, Belen
    Duenas, Carmen
    Garcia-Sanchez, Valle
    Mate, J.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S266 - S266
  • [35] Inflammatory bowel disease: anti-TNF strategies and beyond
    Hoffmann, JC
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S76 - S78
  • [36] Inflammatory bowel disease after anti-TNF drugs
    Hamilton, Louise
    Griffin, Jane
    Dahiya, Sandeep
    Somerville, Margaret
    Stodell, Malcolm
    RHEUMATOLOGY, 2008, 47 : II18 - II18
  • [37] Optimizing anti-TNF treatments in inflammatory bowel disease
    Ben-Horin, Shomron
    Kopylov, Uri
    Chowers, Yehuda
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30
  • [38] Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
    Moran, G. W.
    Lim, A. W. K.
    Bailey, J. L.
    Dubeau, M. -F.
    Leung, Y.
    Devlin, S. M.
    Novak, K.
    Kaplan, G. G.
    Iacucci, M.
    Seow, C.
    Martin, L.
    Panaccione, R.
    Ghosh, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (09) : 1002 - 1024
  • [39] Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
    Schultheiss, Johannes P. D.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1298 - 1308
  • [40] Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
    Sochal, Marcin
    Fichna, Jakub
    Gabryelska, Agata
    Talar-Wojnarowska, Renata
    Bialasiewicz, Piotr
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
12345